1. Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Issue 8 (2nd November 2007) Authors: Gerloni, V; Pontikaki, I; Gattinara, M; Fantini, F Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 8(2008) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0095 Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor-alfa monoclonal antibody (infliximab) in persistently active refractory juvenile idiopathic (chronic) arthritis. an one year open prospective pilot study. (1st June 2001) Authors: Gerloni, V; Pontikaki, I; Desiati, F; Lupi, E; Gattinara, M; Fantini, F Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0522 Correlation between serum calprotectin (MRP8/14), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis. (15th June 2017) Authors: Romano, M; Gerloni, V; Gattinara, M; Lucia, O De; Meroni, PL Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗